your shopping cart is empty.
Choose your country Choose your country

T: +49-30-6392-7878
X: +49-30-6392-7888

USA /Canada:
T: 1.888.578.2660
X: 1.888.578.2666



Content follows


PepMix™ Peptide Pools

Peptide pools of overlapping peptides are a reliable tool for in-vitro stimulation of antigen-specific T-cell in functional T-cell assays such as ELISPOT, cytokine response, effector function or proliferation. JPT’s PepMix™ Peptide Pools are available in a large variety of different tumor associated antigens, viral and bacterial antigens for therapy development, immune monitoring and more. All PepMixesTM are produced in accordance with ISO 9001 regulations ensuring highest batch to batch reproducibility. Each peptide is purified by HPLC and guaranteed for purity and identity. Proprietary production and purification workflows warrant exclusion of contaminations or deletion sequences causing false positive T-cell responses or toxic inhibition. A stringent ADCF policy and low bioburden process assures minimized risk of bacterial endotoxin contamination of our products.
If you do not find what you are looking for in our shop, check our conditions for customized peptide pools.

Infectious Disease Antigens

Many different pathogens are available as ready-to-use PepMixes™ (e.g. EBV, HCMV, influenza, RSV).

PepMix™ Collections

Individual peptide pools combined in one micronic rack for EBV, CMV, cancer and more. 

Tumor Associated Antigens

Peptide pools covering tumor associated antigens (e.g. MAGE, NY-ESO1, PSA, WT1).

Control Pools

Establish reliable and validated T-cell assays using appropriate positive and negative controls.

Epitope Mapping Peptide Set (EMPS)

Matrix Pools enable fast identification of epitopes within an antigen while consuming minimal amounts of material.

Positional Scanning Peptide Library

181 different peptide mixtures to identify stimulating peptides for T-cell clones.


NEW: SARS-COV-2 B.1.1.7(UK) & HCoV NCAP PepMixesTM

(Jan 2021)
Read more

13 NEW Immunopeptidomics Kits

References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more

Infectious diseases beyond COVID-19

JPT's peptide formats in the literature
(Oct 2020)
Read more

SARS COV-2 Mass Spec Reference Kit Released!:

SARS-CoV-2 SpikeMix  for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more

> Read more news!

Quality Assurance

All production is performed according to ISO 9001:2015 standards.

ISO 9001

Stay in touch and be the first to receive the latest news!

Contact us:

JPT Peptide Technologies GmbH
Volmerstrasse 5
12489 Berlin, Germany
Technical Support:
T: +49-30-6392-7878
X: +49-30-6392-7888
USA & Canada:
T: 1.888.JPT.COM0 (1.888.578.2660)
X: 1.888.JPT.COM6 (1.888.578.2666)